NewAmsterdam Pharma Co NV (NAMS)
16.23
+0.40
(+2.53%)
USD |
NASDAQ |
Sep 27, 16:00
16.26
+0.04
(+0.22%)
After-Hours: 20:00
NewAmsterdam Pharma Free Cash Flow: -170.36M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -170.36M |
Free Cash Flow Range, Past 5 Years
-170.36M
Minimum
Jun 2024
-170.36M
Maximum
Jun 2024
-170.36M
Average
-170.36M
Median
Jun 2024
Free Cash Flow Benchmarks
| Koninklijke Philips NV | -- |
| uniQure NV | -110.60M |
| ProQR Therapeutics NV | -39.28M |
| Merus NV | -104.18M |
| argenx SE | -1.276B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -53.98M |
| Cash from Investing (Quarterly) | -0.209M |
| Cash from Financing (Quarterly) | 4.658M |
| Free Cash Flow Per Share (Quarterly) | -0.5721 |
| Free Cash Flow to Equity (Quarterly) | -54.19M |
| Free Cash Flow to Firm (Quarterly) | -54.19M |
| Free Cash Flow Yield | -12.11% |